Across TCGA pan-cancer cohorts, MTCYBP29 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MTCYBP29’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where MTCYBP29 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MTCYBP29 is over-expressed in tumor.

UCEC are the cancer types where MTCYBP29 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTCYBP29 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	IV	+0.205	.014	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: MTCYBP29 RNA expression & survival · all MTCYBP29 data types